![New blood test predicts clinical benefit to IO AND identifies which patient will develop toxicity by Jarushka Naidoo – LUNGevity Foundation](https://oncodaily.com/pub/uploads/2023/09/NADDOOO-2-e1724060854842-1280x721.jpeg)
Photo taken from Jarushka Naidoo/X
Apr 11, 2024, 13:50
New blood test predicts clinical benefit to IO AND identifies which patient will develop toxicity by Jarushka Naidoo – LUNGevity Foundation
LUNGevity Foundation shared on X/Twitter:
“50% patients develop side effects from immunotx. New blood test predicts clinical benefit to IO AND identifies which patient will develop toxicity and require proactive monitoring. Important question esp for PD-L1>50% Great presentation by Jarushka Naidoo. AACR24″
Source: LUNGevity Foundation/X
Aug 22, 2024, 17:45